Skip to main content

Brain-computer interfaces have been implanted in humans for the first time

A Brain-Computer Interface (BCI) is now in clinical trials on human patients, the first time this has ever happened in the United States. With all of the buzz around Neuralink, one might expect this breakthrough would come from Elon Musk’s moonshot company. However, the honor goes to a lesser-known brain interface technology leader, Synchron, and its Stentrode device.

While flashy claims of BCIs allowing VR games without a headset and amplifying human intelligence might make headlines, those are distant dreams. Meanwhile, tangible solutions to medical problems that affect patients today are being addressed by Synchron and other BCI innovators.

This graphic shows how Synchron's BCI with Stentrode and brain.io neuroprosthesis works.
Image used with permission by copyright holder

The Stentrode is an electrode mesh array implanted via the jugular vein using well-established neurointerventional techniques. Since this procedure avoids drilling into the skull and open brain surgery, tens of thousands of physicians and clinics around the world already can perform the operation. That means a large number of patients might benefit from this advance if testing proves it to be safe enough for further use.

Recommended Videos

Combined with Synchron’s neuroprosthesis, brain.io, the Stentrode’s signals are wirelessly transmitted to a computer interface to allow control of a smartphone, tablet, or computer. By enabling easier communication, this technology could bring a major quality-of-life improvement to patients with severe paralysis.

Earlier testing with four patients in Australia has progressed well, with no side effects after 12 months of use. After implantation and training, the patients can, for example, send Whatsapp messages and make online purchases.

Patients in Australia were first to receive Synchron's Brain Computer Interface for BCI testing
Image used with permission by copyright holder

The U.S. Food and Drug Administration (FDA) granted Breakthrough Device designation to Synchron in August of 2020 and on July 6, 2022, the first U.S. patient received a Stentrode. With a series of yes or no signals transmitted via this device, a specially designed app allows text entry and control of a mobile device or computer.

Synchron began work on BCIs in 2012 and the Stentrode has successfully passed through animal testing and is currently in human testing. If everything goes smoothly, the next step will be to demonstrate that this technology significantly improves the patients’ lives. Eventually, this might be a procedure that qualifies for Medicare, which would make it affordable to a large number of patients.

Brain-Computer Interfaces are moving forward at a more rapid pace as each milestone is reached, and once medical use is well-established, consumer uses will follow.

Alan Truly
Alan Truly is a Writer at Digital Trends, covering computers, laptops, hardware, software, and accessories that stand out as…
Gaming monitors have been lying to us, and it’s time they stopped
A gaming monitor playing Forza Horizon 5.

Gaming monitors are lying to us, and they have been for many years. Informed buyers know the tricks that brands play to sell the best gaming monitors, and they've learned to navigate the deceptive marketing. But these ploys persist, and 2023 is the year when monitors need to get a little more transparent.

Some of the key areas where gaming monitors mislead buyers have been running rampant for years, while others are fairly new. As we start a new year and look onto next-gen displays, consider this buying advice for picking up your next gaming display, as well as a call to arms to demand manufacturers do better.
HDR

Read more
Have the Intel Arc GPUs been canceled? I sure hope not
Intel Arc demo: Ryan Shrout plays Shadow of the Tomb Raider on a gaming PC.

A  rumor is circulating that Intel's Arc graphics cards are being canceled, and unlike previous rumors we've heard on the matter, this one seems to hold some weight. The first discrete desktop GPUs from Intel have seen ups and downs since being announced around a year ago, but this is the first word we've gotten that the company may abandon the project.

Headlines and YouTube thumbnails don't tell the full story here, though, and they're primed to spread misinformation considering that Intel's first-gen Arc Alchemist GPUs aren't available in the U.S. yet and should launch soon. It's impossible to say if Arc will eventually bite the dust, but there's a compelling reason it shouldn't.

Read more
Elon Musk plans ‘show and tell’ event on brain-computer technology
Elon Musk stands in front of the Neuralink logo.

Elon Musk, the owner of Neuralink, said the company will be providing an update about its research on October 31. This comes shortly after reports surfaced of Musk's frustration with the slow progress.

Neuralink aims to develop an interface that allows direct connection of a human brain and computer technology. If successful, you might someday expand your processing capabilities and sensory perception through hardware upgrades. That's the futuristic angle that Elon Musk pitched when first introducing this new endeavor.

Read more